top of page
Browse by category
Search
FDA clears Caliway’s CBL-514 for SUPREME-01 study for reducing abdominal subcutaneous fat
Caliway Biopharmaceuticals has announced that the FDA has granted clearance to proceed with SUPREME-01 (CBL-0301), a global,...
Obesity prevalence would shift significantly under proposed new criteria
In the first multinational study of a proposed change to how obesity is defined - which calls for health factors beyond a person's height...
Metabolic bariatric surgery is a cost-effective intervention among individuals with obesity without any comorbidities
Metabolic bariatric surgery (MBS) is a cost-effective intervention among individuals with obesity (BMI > 40 kg/m2) without any...
Pretransplant sleeve gastrectomy improves kidney function
Pretransplant sleeve gastrectomy (SG) improves kidney function and may consequently increase rates of preemptive kidney transplantation...
MBS patients have a greater risk for multiple cancer types compared with the general population
All-cancer incidence risk is similar between patients who underwent metabolic and bariatric surgery (MBS) and the general population,...
AOMs associated with weight recurrence post-treatment
Patients prescribed drugs to help them lose weight may experience a recurrence in weight gain after stopping their anti-obesity...
Browse by tag
bottom of page